Xilio Therapeutics, Inc. (XLO)
0.68
+0.04
(+6.22%)
USD |
NASDAQ |
Jan 02, 16:00
0.68
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Market Cap: 35.70M for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioXcel Therapeutics, Inc. | 37.18M |
| NovaBay Pharmaceuticals, Inc. | 732.75M |
| Palatin Technologies, Inc. | 14.50M |
| Theriva Biologics, Inc. | 8.644M |
| Oragenics, Inc. | 0.6633M |
Market Cap Related Metrics
| PS Ratio | 2.031 |
| Price | 0.68 |
| Earnings Yield | -96.66% |